Syngeneic stem cell transplantation for HIV-related lymphoma

被引:24
作者
Campbell, P [1 ]
Iland, H [1 ]
Gibson, J [1 ]
Joshua, D [1 ]
机构
[1] Royal Prince Alfred Hosp, Kanematsu Labs, Inst Haematol, Camperdown, NSW 2050, Australia
关键词
HIV; lymphoma; syngeneic; transplant; antiretrovirals;
D O I
10.1046/j.1365-2141.1999.01422.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment of human immunodeficiency virus (HIV)-related lymphoma is beset by a number of therapeutic limitations. High-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT) for relapsed disease is one option, but may be compromised by unacceptable treatment-related morbidity and mortality. We describe an HIV-positive male with relapsed immunoblastic non-Hodgkin's lymphoma (NHL) who successfully received salvage chemotherapy followed by a syngeneic PBSCT from his HIV-negative (hepatitis C positive) brother. At 15 months post transplant he remains in complete remission with low-level HIV viral load, an improved CD4 lymphocyte count and absent anti-hepatitis C antibodies. We believe selected patients with relapsed HIV-related NHL should be considered for high-dose therapy.
引用
收藏
页码:795 / 798
页数:4
相关论文
共 11 条
[1]  
BEX F, 1994, BLOOD, V84, P3317
[2]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[3]  
CHAMPLIN RE, 1997, AM SOC CLIN ONCOLOGY, P88
[4]   Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection [J].
Kaplan, LD ;
Straus, DJ ;
Testa, MA ;
VonRoenn, J ;
Dezube, BJ ;
Cooley, TP ;
Herndier, B ;
Northfelt, DW ;
Huang, J ;
Tulpule, A ;
Levine, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (23) :1641-1648
[5]   SYNGENEIC BONE-MARROW TRANSPLANTATION AND ADOPTIVE TRANSFER OF PERIPHERAL-BLOOD LYMPHOCYTES COMBINED WITH ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION [J].
LANE, HC ;
ZUNICH, KM ;
WILSON, W ;
CEFALI, F ;
EASTER, M ;
KOVACS, JA ;
MASUR, H ;
LEITMAN, SF ;
KLEIN, HG ;
STEIS, RG ;
LONGO, DL ;
FAUCI, AS .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) :512-519
[6]   AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA [J].
PHILIP, T ;
GUGLIELMI, C ;
HAGENBEEK, A ;
SOMERS, R ;
VANDERLELIE, H ;
BRON, D ;
SONNEVELD, P ;
GISSELBRECHT, C ;
CAHN, JY ;
HAROUSSEAU, JL ;
COIFFIER, B ;
BIRON, P ;
MANDELLI, F ;
CHAUVIN, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1540-1545
[7]   Diagnosis and management of systemic non-Hodgkin's lymphoma in HIV disease [J].
Sandler, AS ;
Kaplan, LD .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (05) :1111-&
[8]   Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients [J].
Schmitz, N ;
Linch, DC ;
Dreger, P ;
Goldstone, AH ;
Boogaerts, MA ;
Ferrant, A ;
Demuynck, HMS ;
Link, H ;
Zander, A ;
Barge, A ;
Borkett, K .
LANCET, 1996, 347 (8998) :353-357
[9]   Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma [J].
Sparano, JA ;
Wiernik, PH ;
Hu, XP ;
Sarta, C ;
Schwartz, EL ;
Soeiro, R ;
Henry, DH ;
Mason, B ;
Ratech, H ;
Dutcher, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :3026-3035
[10]   Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients [J].
Vaccher, E ;
Tirelli, U ;
Spina, M ;
Talamini, R ;
Errante, D ;
Simonelli, C ;
Carbone, A .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2217-2223